Please Wait...

Case Studies

These clinical trial management case studies will help you learn from the success of others as well as provide you with industry knowledge. Please click on the case study you wish to read below to learn more.

A global pharmaceutical company with headquarters in Japan was using the services of another vendor to submit cases that occurred in Japan (domestic) and cases that occurred outside of Japan (foreign cases) to the PMDA. The company explored several options. Due to Bioclinca’s strong pharmacovigilance expertise and high quality, the company decided to partner with Bioclinica for their end-to-end case processing needs.

Conducting clinical trials for rare, debilitating diseases can be particularly challenging, owing to the smaller patient population with limited mobility and greater caregiving requirements. Direct-to-patient shipping of clinical trial drugs, while not typical, might help to reach these patient populations who otherwise would struggle to participate in and comply with clinical trials. However, implementation of this strategy is challenging because of many reasons such as the logistical considerations and regulatory requirements regarding patient confidentiality and quality control.

Read our case study and learn how Bioclinica collaborated with a sponsor to successfully ship study drugs directly to patients.

Having grown to a premier research organization with 400 clinical trials to its credit, HCRI's clinical trial management needs had surpassed the conventional processes it had been using to manage and monitor information and documents related to its clinical studies. The Institute's 140 users relied on Excel spreadsheets and other manual processes that proved labor-intensive, inefficient, and a barrier to team communication.

Read our case study and learn how Bioclinica's OnPoint CTMS creates a centralized environment and provides a highly efficient way to manage clinical trials and streamline clinical operations.

Before engaging with Bioclinica, this CRO used a manual process to calculate payments for almost all of their studies. This admin-intensive process was resource-intensive, slow and error-prone, and the CRO knew they needed an automated system that could provide accurate payments in a much timelier fashion.

Read our case study and learn how Bioclinica has helped this CRO to become fully self-service and seamlessly make payments to sites around the world in a timelier, more accurate, efficient manner.

Given that attaining sites has become increasingly competitive globally, this sponsor recognized that with their large studies (and the large number of sites required to perform those studies), it was crucial to keep their sites satisfied by paying them accurately and on time.

Read our case study and learn how Bioclinica was able to fully integrate all of the trial sites into their system.

Bioclinica understands the pain points of both sponsors and sites when it comes to the financial management of clinical trials. ClinPay and ClinViz are two examples of technology solutions within the Bioclinica suite of Financial Lifecycle Solutions (FLS); the former automates the financial management of clinical trials by initiating timely and accurate payments based on Electronic Data Capture (EDC) and Clinical Trial Management System (CTMS) data, as well as transparency for the sponsor regarding the payments sent and requested, and the latter is the payee (site) portal that provides sites with real-time access to their complete history. Essentially, payments from the sponsor are initiated, recorded and tracked in ClinPay, and sites have access to all of the payment details through ClinViz.

Read our case study and learn how Bioclinica's ClinViz, when partnered with ClinPay, provides a unified site payment portal solution. We will discuss how a sponsor recently transitioned from a manual payment process to the use of ClinPay for site payments.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (18 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (19 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (19 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (19 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (19 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (19 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices